is ariad still waiting for an approval on ponatinib over in europe and asia? and if so, do you guys think that upon approval in those territories, the share price will follow a similar reaction, as it did last week?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.